شفاف سازی و فساد در مراقبت سلامت و تحقیقات بهداشت درمان

عنوان فارسی:        تمامیت، شفافیت و فساد مراقبت بهداشتی و تحقیقات سلامت، جلد 1

عنوان انگلیسی:    Integrity, Transparency and Corruption in Healthcare & Research on Health, Volume I

This book grapples with the numerous risks organizations face in order to succeed.  These include economic risks, disaster risks, supply-chain risks, regulatory risks, and technology risks, all of which affect organizations in different ways and in varying degrees. Referencing Mahatma Gandhi’s seven unethical behaviors in the business world—wealth without work, pleasure without conscience, knowledge without character, commerce without morality, science without humanity, religion without sacrifice, and politics without principle—the authors analyze the healthcare sector.  As competition in the health sector increases, there has also been a rise in unethical behavior. Corruption in the health sector results in severe consequences as it could affect the health of millions. This volume explores fraud schemes and cases, legislation to avoid cheating, lack of law, transparency, ethical issues, corporate governance and transparency in the health and pharmaceutical sector bringing together the perspectives of practitioners, professionals, as well as academic authors.

1. Transparency and Conflicts in Science: History of Influence, Scandal, and Denial
2. The Health Impact Fund and the Problem of Corruption in the Global Pharmaceutical Sector
3. Outsourced Services in Private Healthcare Organizations and ISAE 3402 Assurance Engagement: A Research Focused on Turkey
4. Revisiting Accountability: Corruption in Health Care in Developing Countries
5. Corruption of the Canadian Drug Regulatory System
6. Professional Ethics, Professionalization, and Regulation of Pharmaceutical Sales Representatives: Analyzing the Costa Rican Case
7. Exploring Accountability and Transparency Within International Organizations: What Do We Know and What Do We Need to Know?
8. Medical Ghost- and Guest-Writing as Corrupt Practices and How to Prevent Them
9. Fraudulent Misrepresentation and Fraudulent Concealment in Products Liability in Tort Law in Canada: The Special Relationship Between Drug Companies and Consumers in the Context of the Fraudulent Misrepresentation and Fraudulent Concealment of Data
10. Developing Governance of Procurement Department in Hospitals
11. Communicating Integrity Framework Information on Malaysian Private Hospitals’ Websites